OHSU Cancer Institute scientists report more accurate prognosis of colon cancer survival

June 05, 2006

ATLANTA, Ga. -- Scientists at Oregon Health & Science University Cancer Institute and five other institutions have found a more accurate way to report and predict the survival of colon cancer patients by calculating a statistic called conditional survival. Conditional survival takes into account the time already survived since diagnosis.

Patients usually receive an estimate of their survival probability only when their disease is initially diagnosed. But after a patient has remained disease-free one year or more later, his or her prognosis may change, and often improves.

The results of the study will be presented on Monday, June 5 at the 2006 annual meeting of the American Society of Clinical Oncology in Atlanta, Ga. The presentation is one of eight abstracts authored by members of OHSU's Department of Radiation Medicine to be accepted for presentation at the conference.

Led by Samuel J. Wang, M.D., Ph.D., Holman Research Pathway resident at OHSU, in collaboration with Charles R. Thomas, Jr., M.D., professor and chair of the Department of Radiation Medicine (http://www.ohsu.edu/radonc), and seven other scientists, the study analyzed 5,587 colon cancer research subjects who were enrolled in four National Surgical Adjuvant Breast & Bowel Project (NSABP) trials to determine their five-year conditional survival rates.

Subjects in the study had already survived without disease recurrence for up to five years after diagnosis. The results were sorted by number of years since diagnosis, age, sex, race, stage of disease, location of tumors and other factors.

The results showed that as more time elapsed since diagnosis, most subjects experienced an improvement in their subsequent five-year conditional survival following the initial disease-free period. For instance, at the time of diagnosis, patients had a 76 percent probability of surviving five years, but those who had already survived disease-free for five years had a 90 percent chance of surviving an additional five years.

"This study confirms that a patient's prognosis usually improves as he or she survives disease-free for longer periods of time from initial diagnosis," Wang said. "These new conditional survival tables will allow physicians to give patients more accurate survival estimates after they have already survived a period of time since their diagnosis and treatment."

Other participating institutions were the University of Texas Health Science Center at San Antonio; the University of Pittsburgh; the University of Chicago; the AMC Cancer Research Center in Denver; and Allegheny General Hospital in Pittsburgh.

ASCO Abstract No. 5519: Conditional Survival for Patients with Colon Cancer: An Analysis of National Surgical Adjuvant Breast and Bowel Project

To access all OHSU news releases, visit www.ohsu.edu/news/

Oregon Health & Science University

Related Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.

Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.

Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).

30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.

Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.

Read More: Disease News and Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.